financetom
Business
financetom
/
Business
/
Real estate broker eXp posts Q2 revenue in line with expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Real estate broker eXp posts Q2 revenue in line with expectations
Jul 31, 2025 2:09 PM

Overview

* eXp World Holdings ( EXPI ) Q2 revenue rises 1% to $1.3 bln, almost in line with analyst expectations, per LSEG data

* Adjusted EBITDA of $11.2 mln missed analyst estimates, per LSEG data

* Company reported a net loss of $2.3 mln

Result Drivers

* AGENT-FIRST MODEL - eXp attributes resilience to its agent-first model and commitment to innovation

* INTERNATIONAL GROWTH - Rapid growth in international business with robust agent productivity and expanding global reach, according to the company

* STRATEGIC INVESTMENTS - Increased operating expenses driven by strategic investments to streamline operations and severance costs

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Miss $1.30 $1.30

Revenue bln bln (2

Analysts

)

Q2 Net -$2.30

Income mln

Q2 Miss $11.20 $25.90

Adjusted mln mln (2

EBITDA Analysts

)

Q2 $0.05

Dividend

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the real estate services peer group is "buy"

* Wall Street's median 12-month price target for eXp World Holdings Inc ( EXPI ) is $12.00, about 9.7% above its July 30 closing price of $10.84

* The stock recently traded at 155 times the next 12-month earnings vs. a P/E of 48 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
LXP Industrial Trust Q1 Adjusted FFO Flat, Revenue Rises; Fiscal 2025 Adjusted FFO Outlook Reaffirmed
LXP Industrial Trust Q1 Adjusted FFO Flat, Revenue Rises; Fiscal 2025 Adjusted FFO Outlook Reaffirmed
May 25, 2025
06:53 AM EDT, 05/01/2025 (MT Newswires) -- LXP Industrial Trust ( LXP ) reported Q1 adjusted company funds from operations Thursday of $0.16 per share, flat with a year earlier. Four analysts polled by FactSet expected $0.14. Revenue for the quarter ended March 31 was $88.9 million, up from $86.3 million a year earlier. Analysts surveyed by FactSet expected $80.9...
Investment giant KKR's first-quarter profit climbs on fee growth
Investment giant KKR's first-quarter profit climbs on fee growth
May 25, 2025
(Reuters) -KKR reported a nearly 20% jump in first-quarter profit on Thursday, buoyed by higher management and transaction fees it earned from its portfolio. The results reflect the structural advantage held by large alternative asset managers, which can generate hundreds of millions in management fees even when asset sales are muted. But market uncertainty driven by President Donald Trump's tariffs...
Eli Lilly posts strong Q1 results, but weight-loss drug sales disappoint
Eli Lilly posts strong Q1 results, but weight-loss drug sales disappoint
May 25, 2025
(Reuters) - Eli Lilly ( LLY ) on Thursday posted better-than-expected first quarter revenue and profit, although sales of its popular weight-loss drug, Zepbound, came in slightly below Wall Street estimates, sending its shares down 2% in premarket trading. The success of the company's diabetes and weight loss treatments has led Eli Lilly ( LLY ) to become the world's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved